The role of phosphodiesterase type-5 inhibitors in treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia

Lignende værker

• Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia
  af: Pattanaik, Smita, et al.
  Udgivet: (2018)
• Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia, Erectile Dysfunction, and Phosphodiesterase-5 Inhibitors
  af: Roehrborn, Claus G
  Udgivet: (2004)
• Update on Phosphodiesterase Type 5 Inhibitors for the Treatment of Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia
  af: Elterman, Dean S, et al.
  Udgivet: (2012)
• The relationships between metabolic syndrome, erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia
  af: Doğan, Yunus, et al.
  Udgivet: (2015)
• Are phosphodiesterase type 5 inhibitors effective for the management of lower urinary symptoms suggestive of benign prostatic hyperplasia?
  af: Zhang, Li Tao, et al.
  Udgivet: (2015)